CARBAMAZEPINE - ANVISA Registration 10287411418

Access comprehensive regulatory information for CARBAMAZEPINE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411418 and manufactured by ROCHE DIAGNOSTICS GMBH. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Feb 10, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including MICROGENICS CORPORATION, ABBOTT GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10287411418
2 Related Devices
Registration Details
ANVISA Registration Number: 10287411418
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

CARB4 (ONLINE TDM Carbamazepine Gen.4)_cobas c
Risk Class III

Registration Details

10287411418

25351203161201908

30280358000186

Company Information

Germany
PT: ALEMANHA

Dates and Status

Jul 29, 2019

10/02/2035

09/18/2025 19:00:01

CARB4 (ONLINE TDM Carbamazepine Gen.4)_cobas c
Risk Class III

Registration Details

10287411418

25351203161201908

30280358000186

Company Information

Dates and Status

Jul 29, 2019

10/02/2035

09/18/2025 19:00:01